1039P First-in-human phase I study of givastomig, a novel Claudin 18.2/4-1BB bispecific antibody in advanced solid tumors.
Saved in:
| Title: | 1039P First-in-human phase I study of givastomig, a novel Claudin 18.2/4-1BB bispecific antibody in advanced solid tumors. |
|---|---|
| Authors: | Ku, G.1 (AUTHOR), Shen, L.2 (AUTHOR), Klempner, S.J.3 (AUTHOR), Pan, H.4 (AUTHOR), Kratz, J.5 (AUTHOR), Liang, X.6 (AUTHOR), Deng, Y.7 (AUTHOR), Kim, S.8 (AUTHOR), Wang, Z.9 (AUTHOR), Feller, L.10 (AUTHOR), Powderly, J.11 (AUTHOR), Dayyani, F.12 (AUTHOR), Schneider, R.E.13 (AUTHOR), Girda, E.14 (AUTHOR), Berlin, J.D.15 (AUTHOR), Spencer, K.16 (AUTHOR), Nguyen, M.T.17 (AUTHOR), Wang, V.17 (AUTHOR), Xu, C.17 (AUTHOR), Zhu, A.18 (AUTHOR) |
| Source: | Annals of Oncology. 2023 Supplement 2, Vol. 34, pS631-S631. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 173098971 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1039P First-in-human phase I study of givastomig, a novel Claudin 18.2/4-1BB bispecific antibody in advanced solid tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Ku%2C+G%2E%22">Ku, G.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shen%2C+L%2E%22">Shen, L.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Klempner%2C+S%2EJ%2E%22">Klempner, S.J.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pan%2C+H%2E%22">Pan, H.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kratz%2C+J%2E%22">Kratz, J.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liang%2C+X%2E%22">Liang, X.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Deng%2C+Y%2E%22">Deng, Y.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kim%2C+S%2E%22">Kim, S.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Z%2E%22">Wang, Z.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Feller%2C+L%2E%22">Feller, L.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Powderly%2C+J%2E%22">Powderly, J.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dayyani%2C+F%2E%22">Dayyani, F.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schneider%2C+R%2EE%2E%22">Schneider, R.E.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Girda%2C+E%2E%22">Girda, E.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Berlin%2C+J%2ED%2E%22">Berlin, J.D.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Spencer%2C+K%2E%22">Spencer, K.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nguyen%2C+M%2ET%2E%22">Nguyen, M.T.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+V%2E%22">Wang, V.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+C%2E%22">Xu, C.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhu%2C+A%2E%22">Zhu, A.</searchLink><relatesTo>18</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2023 Supplement 2, Vol. 34, pS631-S631. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=173098971 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2023.09.2178 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S631 Titles: – TitleFull: 1039P First-in-human phase I study of givastomig, a novel Claudin 18.2/4-1BB bispecific antibody in advanced solid tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ku, G. – PersonEntity: Name: NameFull: Shen, L. – PersonEntity: Name: NameFull: Klempner, S.J. – PersonEntity: Name: NameFull: Pan, H. – PersonEntity: Name: NameFull: Kratz, J. – PersonEntity: Name: NameFull: Liang, X. – PersonEntity: Name: NameFull: Deng, Y. – PersonEntity: Name: NameFull: Kim, S. – PersonEntity: Name: NameFull: Wang, Z. – PersonEntity: Name: NameFull: Feller, L. – PersonEntity: Name: NameFull: Powderly, J. – PersonEntity: Name: NameFull: Dayyani, F. – PersonEntity: Name: NameFull: Schneider, R.E. – PersonEntity: Name: NameFull: Girda, E. – PersonEntity: Name: NameFull: Berlin, J.D. – PersonEntity: Name: NameFull: Spencer, K. – PersonEntity: Name: NameFull: Nguyen, M.T. – PersonEntity: Name: NameFull: Wang, V. – PersonEntity: Name: NameFull: Xu, C. – PersonEntity: Name: NameFull: Zhu, A. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 10 Text: 2023 Supplement 2 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 34 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |